卵巢上皮癌术后一线化疗被引量：14

The first-line adjuvant chemotherapy for epithelial ovarian carcinoma

下载PDF

导出

摘要卵巢上皮癌对化疗相对敏感 ,术后化疗是大部分患者治疗中必不可少的组成部分。术后化疗方案经历了从非铂类到铂类化疗、单剂化疗到联合化疗、紫杉醇的临床广泛应用、腹腔化疗、早期卵巢癌化疗以及各种新药方案等阶段 ,现综述卵巢上皮癌的术后一线化疗。

作者赵晓东张毅

机构地区北京医院妇产科

出处《国外医学（肿瘤学分册）》 2004年第4期295-299,共5页 Foreign Medical Sciences (Cancer Section)

关键词卵巢上皮癌术后化疗联合用药用药途径

分类号 R737.31 [医药卫生—肿瘤] R730.53 [医药卫生—肿瘤]

引文网络
相关文献

参考文献27

1Advanced Ovarian Trialists' Group. Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists'Group. Br J Cancer, 1998,78(11) :1479-1487.
2McGuire WP, Hoskins WJ, Brady MF, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage Ⅲ and stage Ⅳ ovarian cancer. N Engl J Med, 1996,334(1): 1-6.
3Piccart MJ, Bertelsen K, James K, et al. Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results. J Natl Cancer Inst, 2000,92(9) :699-708.
4Muggia FM,Braly PS,Brady MF, et al. Phase Ⅲ randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage Ⅲ or Ⅳ ovarian cancer:a gynecologic oncology group study. J Clin Oncol, 2000,18 ( 1 ): 106-115.
5Colombo N,on behalf of the ICON collaborators. Randomized trial of paclitaxel and carboplatin versus a control arm of carboplatin or CAP: the third international collaborative ovarian neoplasm study.Proc Am Soc Clin Oncol,2000,19:379a.
6International Collaborative Ovarian Neoplasm Group. Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial. Lancet,2002,360(9332) :505-515.
7The ICON Collaborators. ICON2: randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide,doxorubicin,and cisplatin) in women with ovarian cancer.ICON Collaborators. International Collaborative Ovarian Neoplasm Study. Lancet, 1998,352(9140) :1571-1576.
8Luck HJ, Du Bois A, Weber B, et al. The integration of anthracyclines in the treatment of advanced ovarian cancer. Int J Gynecol Cancer,2001,11 (Suppl 1) :34-38.
9Romanini A, Tanganelli L, Camino F, et al. First-line chemotherapy with epidoxoruicin, paclitaxel,and carboplatin for the treatment of advanced epithelial ovarian cancer patients. Gynecol Oncol, 2003,89(3) :354-359.
10Neijt JP, Engelholm SA, Tuxen MK, et al. Exploratory phase Ⅲ study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer. J Clin Oncol, 2000,18 ( 17 ): 3084-3092.